Hepatitis C Virus and Vaccine Development

The prevalence of Hepatitis C virus (HCV) is approximately 3% around the world. This virus causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The effectiveness of interferon-α and ribavirin therapy is about 50% and is associated with significant toxicity and cost. Hence, generat...

Descripción completa

Detalles Bibliográficos
Autores principales: Naderi, Malihe, Gholipour, Naghmeh, Zolfaghari, Mohammad Reza, Moradi Binabaj, Maryam, Yegane Moghadam, Ahmad, Motalleb, Gholamreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Babol University of Medical Sciences 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293608/
https://www.ncbi.nlm.nih.gov/pubmed/25635247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293608/
https://www.ncbi.nlm.nih.gov/pubmed/25635247

Ejemplares similares